Advertisement
Screener

SpyGlass Pharma, Inc. (SGP) Deferred Tax Liabilities, Gross

2.8 / 5 stars · 68/120 Roast Me

SpyGlass Pharma, Inc. Deferred Tax Liabilities, Gross

SpyGlass Pharma, Inc. (SGP) had Deferred Tax Liabilities, Gross of $462.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-26

  • 2025-12-31: Deferred Tax Liabilities, Gross $462.00K.
  • 2024-12-31: Deferred Tax Liabilities, Gross $907.00K.
Period endDeferred Tax Liabilities, Gross
2025-12-31$462.00K
10-K · filed 2026-03-26
2024-12-31$907.00K
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B